Publications

Advancing Science Through Publication

The TDF Publications Repository

Get a better understanding about how our initiatives in TB, HIV, and clinical research contribute to public health, as demonstrated through our annual reports and peer-reviewed publications.

No annual reports found.

Predictors of sputum culture conversions among patients treated for multidrug-resistant tuberculosis

Kurbatova EV, Gammino VM, Bayona J.,Becerra MC, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Taylor A, Viikleapp P, Zignol M, Cegielski P

Int J Tuberc Lung Dis. 2012 Oct;16(10):1335-43.

Screening outcomes from patients with suspected multidrug-resistant tuberculosis: lessons learned in the Philippines

Gler MT, Guilatco RS, Guray CV, Tupasi TE.

Int J Tuberc Lung Dis. 2012 Oct;16(10):1326-30. doi: 10.5588/ijtld.12.0038. Epub 2012 Aug 3.

Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects

Kurbatova EV, Taylor A, Gammino VM, Bayona J, Becerra M, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Viiklepp P, Zignol M, Cegielski JP.

Tuberculosis (Edinb). 2012 Sep;92(5):397-403. doi: 10.1016/j.tube.2012.06.003. Epub 2012 Jul 10.

Impact of patient and program factors on default during treatment of multidrug-resistant tuberculosis

Gler MT, Podewils LJ, Munez N, Galipot M, Quelapio MI, Tupasi TE.

Int J Tuberc Lung Dis. 2012 Jul;16(7):955-60. doi: 10.5588/ijtld.11.0502. Epub 2012 May 7.

Delamanid for multidrug-resistant pulmonary tuberculosis

Gler MT, Skripconoka V, Sanchez-Garavito E, Xiao H, Cabrera-Rivero JL, Vargas-Vasquez DE, Gao M, Awad M, Park SK, Shim TS, Suh GY, Danilovits M, Ogata H, Kurve A, Chang J, Suzuki K, Tupasi T, Koh WJ, Seaworth B, Geiter LJ, Wells CD.

N Engl J Med. 2012 Jun 7;366(23):2151-60. doi: 10.1056/NEJMoa1112433.

PMID:

Impact of patient and program factors on default during treatment of multidrug–resistant tuberculosis

Gler MT, Podewils LJ, Munez N, Galipo, Quelapio MI, Tupasi TE.

Int J Tuberc Lung Dis 7 May 2012, 16(7); 955-960.

Frequency and type of microbiological monitoring of multidrug-resistant tuberculosis treatment

Kurbatova EV, Gammino VM, Bayona J, Becerra M, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Taylor A, Viiklepp P, Zignol M, Cegielski JP.

Int J Tuberc Lung Dis. 2011 Nov;15(11)1553-5.

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis

Vassall A, van Kampen S, Sohn H, Michael JS, John KR, den Boon S, Davis JL, Whitelaw A, Nicol MP, Gler MT, MT, Khaligov A, Zamudio C, Perkins MD, Hoehme CC, Cobelens F.

PLoS Med 2011, Nov;8(11):e1001120.

Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects

Gammino VM, Taylor AB, Rich ML, Bayona J, Becerra MC, Bonilla C, Gelmanova I, Hollo V, Jaramillo E, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riektsina V, TupasiTE, Wells CD, Zignol M, Cegielski PJ.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1315-22. doi: 10.5588/ijtld.10.0221.